Additionally, PGD activation increased the chemo- and immune-resistance of renal cell carcinoma (RCC) cells, and PGD inhibition made RCC cells sensitive to chemotherapy and immunotherapy (such as IFN-α) (44). This evidence concerns the gene PGD and hereditary clear cell renal cell carcinoma.